While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

while pharma (pharmaceutical) companies develop drugs from chemicals. Image source: Getty Images. There are even different regulatory paths for biotech and pharma products in the U.S. Companies ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ ... Analysts predict that a rate decline might free up billions of dollars in investment money set ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A Rocket ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

HYDERABAD: The National Company Law Tribunal has sanctioned the scheme of amalgamation between contract development and manufacturing organisation (CMDO) players Suven Pharmaceuticals Ltd and ...

Corvus Pharmaceuticals' stock has experienced volatility due to mixed clinical data, particularly from their lead asset soquelitinib's Phase 1 trial in atopic dermatitis. The company has promising ...

Claim your 7-day free trial now. RBC Capital analyst Brian Abrahams, on Feb. 20, maintained Vertex Pharmaceuticals with ... saying the stock is close to its 52-week high. Supporting his view ...

including receipt of approval from the Department of Pharmaceuticals, where applicable. The effective date will be duly intimated to the stock exchanges for public disclosure in accordance with ...